the new oral drug Dificid (fidaxomicin) for Clostridium difficile diarrhea

July 2011

Reps will promote that the new oral drug Dificid (fidaxomicin) for Clostridium difficile diarrhea is superior to oral vancomycin.

That's because Dificid works at least as well as vanco to control C. diff...but seems to have a lower risk of recurrence.

There's one less recurrence within one month for every 10 patients treated with Dificid instead of oral vancomycin.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote